Use of insulin or sulfonylureas as second-line treatment in adults with type 2 diabetes is associated with increased cardiovascular risk, whereas use of newer classes of glucose-lowering drugs is not, ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Sulfonylureas, the first family of oral drugs used for treating type 2 ...

Neonatal diabetes can result from mutations in either Kir6.2 or SUR1 subunits of the pancreatic potassium ATP channel, which disrupt insulin release. Sulfonylureas close these channels and restore ...

For better glycemic control in diabetic patients, some studies recommend using the combination of NPH or insulin lispro with sulfonylurea. What is the rationale behind such combinations, given that ...

People with type 2 diabetes treated with metformin plus a sulfonylurea with high affinity for cardiac mitochondrial adenosine triphosphate–sensitive potassium (mitoK ATP) channels, such as glyburide ...

Sulfonylureas are an older class of type 2 diabetes therapy but remain the most commonly prescribed antidiabetic drug after metformin. Patients taking metformin for type 2 diabetes (T2D) who switch to ...

Insured, adult patients with type 2 diabetes that received sulfonylureas or basal insulin as a second-line antidiabetic medication therapy were at increased risk for certain CV events, according to ...

Background and goal: Sulfonylureas are a class of oral medications used to manage blood glucose levels in patients with type 2 diabetes. These drugs increase insulin production regardless of blood ...

Sulfonylurea type 2 diabetes drugs are linked to a higher long-term risk of an impaired awareness of hypoglycemic episodes, according to a new study from Taiwan. From 5 years of use onward, the study ...

The subjects of the study were 228 diabetic children, 104 boys and 124 girls. All were under sixteen years of age. With few exceptions, all were in summer camps for diabetic children and leading ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Lean older adults with type 2 diabetes ...